Results of a Phase 2 Clinical Trial of Neo-Adjuvant Temozolomide (TMZ), Followed by Concurrent TMZ and Hypofractionated Accelerated External Beam Radiation Therapy (Ac-EBRT) With Limited Margins, and Adjuvant TMZ for Patients With Glioblastoma Multiforme (GBM)

✍ Scribed by Shenouda, G.; Souhami, L.; Panet-Raymond, V.; Abdulkarim, B.; Cury, F.; Owen, S.; Kavan, P.; Petrecca, K.; Guiot, M.

• Book ID: 122256597
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 45 KB
• Volume: 87
• Category: Article
• ISSN: 0360-3016
• DOI: 10.1016/j.ijrobp.2013.06.412